Anatoly A. Starkov

Dr. Anatoly A. Starkov


Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 1997 in FEBS Letters
Verified
Journal Article
Closed access
SKSergey S. Korshunov
Sergey S. Korshunov
VSVladimir P. Skulachev
Vladimir P. Skulachev
ASAnatoly A. Starkov
Anatoly A. Starkov

1 February 2005 in Biochemistry (Moscow)
Verified
Journal Article
Closed access
PDF file
AAA. Yu. Andreyev
A. Yu. Andreyev
YKYu. E. Kushnareva
Yu. E. Kushnareva
ASAnatoly A. Starkov
Anatoly A. Starkov

8 December 2008 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
ASAnatoly A. Starkov
Anatoly A. Starkov

8 September 2004 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
ASAnatoly A. Starkov
Anatoly A. Starkov
GFGary Fiskum
Gary Fiskum
Christos ChinopoulosChristos Chinopoulos
Christos Chinopoulos
BLBeverly J. Lorenzo
Beverly J. Lorenzo
SBSusan E. Browne
Susan E. Browne
MBM. Flint Beal
M. Flint Beal
Mitochondria-produced reactive oxygen species (ROS) are thought to contribute to cell death caused by a multitude of pathological conditions. The molecular sites of mitochondrial ROS production are not well established but are generally thought to be located in complex I and complex III of the electron transport chain. We measured H2O2production, respiration, and NADPH reduction level in rat brain mitochondria oxidizing a variety of respiratory substrates. Under conditions of maximum respiration induced with either ADP or carbonyl cyanidep-trifluoromethoxyphenylhydrazone,α-ketoglutarate supported the highest rate of H2O2production. In the absence of ADP or in the presence of rotenone, H2O2production rates correlated with the reduction level of mitochondrial NADPH with various substrates, with the exception of α-ketoglutarate. Isolated mitochondrial α-ketoglutarate dehydrogenase (KGDHC) and pyruvate dehydrogenase (PDHC) complexes produced superoxide and H2O2. NAD+inhibited ROS production by the isolated enzymes and by permeabilized mitochondria. We also measured H2O2production by brain mitochondria isolated from heterozygous knock-out mice deficient in dihydrolipoyl dehydrogenase (Dld). Although this enzyme is a part of both KGDHC and PDHC, there was greater impairment of KGDHC activity in Dld-deficient mitochondria. These mitochondria also produced significantly less H2O2than mitochondria isolated from their littermate wild-type mice. The data strongly indicate that KGDHC is a primary site of ROS production in normally functioning mitochondria.

11 August 2003 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
ASAnatoly A. Starkov
Anatoly A. Starkov
GFGary Fiskum
Gary Fiskum
Mitochondrial production of reactive oxygen species (ROS) at Complex I of the electron transport chain is implicated in the etiology of neural cell death in acute and chronic neurodegenerative disorders. However, little is known regarding the regulation of mitochondrial ROS production by NADH‐linked respiratory substrates under physiologically realistic conditions in the absence of respiratory chain inhibitors. This study used Amplex Red fluorescence measurements of H2O2 to test the hypothesis that ROS production by isolated brain mitochondria is regulated by membrane potential (ΔΨ) and NAD(P)H redox state. ΔΨ was monitored by following the medium concentration of the lipophilic cation tetraphenylphosphonium with a selective electrode. NAD(P)H autofluorescence was used to monitor NAD(P)H redox state. While the rate of H2O2 production was closely related to ΔΨ and the level of NAD(P)H reduction at high values of ΔΨ, 30% of the maximal rate of H2O2 formation was still observed in the presence of uncoupler (p‐trifluoromethoxycarbonylcyanide phenylhydrazone) concentrations that provided for maximum depolarization of ΔΨ and oxidation of NAD(P)H. Our findings indicate that ROS production by mitochondria oxidizing physiological NADH‐dependent substrates is regulated by ΔΨ and by the NAD(P)H redox state over ranges consistent with those that exist at different levels of cellular energy demand.

1 April 2000 in Annual Review of Pharmacology and Toxicology
Verified
Journal Article
Closed access
KWK. B. Wallace
K. B. Wallace
ASAnatoly A. Starkov
Anatoly A. Starkov
Mitochondria have long been recognized as the generators of energy for the cell. Like any other power source, however, mitochondria are highly vulnerable to inhibition or uncoupling of the energy harnessing process and run a high risk for catastrophic damage to the cell. The exquisite structural and functional characteristics of mitochondria provide a number of primary targets for xenobiotic-induced bioenergetic failure. They also provide opportunities for selective delivery of drugs to the mitochondrion. In light of the large number of natural, commercial, pharmaceutical, and environmental chemicals that manifest their toxicity by interfering with mitochondrial bioenergetics, it is important to understand the underlying mechanisms. The significance is further underscored by the recent identification of bioenergetic control points for cell replication and differentiation and the realization that mitochondria play a determinant role in cell signaling and apoptotic modes of cell death.